0
0
12/19/22 at 1:18pm
Organization
Contagionlive.com
Author
John Parkinson
39 words
0
Comments
The New Drug Application (NDA) for the company’s investigational therapy, Olorofim, looks to serve an unmet medical need in this treatment space.
You are the first to view
https://www.contagionlive.com/view/f2g-announces-fda-filing-acceptance-of-nda-for-the-treatment-of-invasive-fungal-infections
Create an account
or login to join the discussion